Motion Sickness Relief Tablet, Chewable
Product Images NDC 51013-322

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Motion Sickness Relief (NDC 51013-322). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Puracap Pharmaceutical Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cvsb36-00 (Cvsb36 00)

Cvsb36-00 (Cvsb36 00)
This is a product warning label for a medication. It advises consulting a doctor or pharmacist before use if taking sedatives or tranquilizers, as the product can cause drowsiness. It also warns against the use of alcohol, sedatives, or tranquilizers while taking the product. The label advises caution when driving or operating machinery after using the product and recommends speaking to a doctor before use during pregnancy or while breastfeeding. The medication should be kept out of reach of children, and in case of overdose, medical assistance should be sought or the Poison Control Center contacted. The directions recommend taking the first dose one hour before starting an activity and suggest taking one or two tablets as directed by a doctor for children aged 12 or older. The medication contains aspartame, sugar, sodium, magnesium stearate, and microcrystalline cellulose, among other ingredients. It provides contact information for questions or comments and advises reading all product information carefully before use.*
FDA Label Image

Cvsf36-00 (Cvsf36 00)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.